Monthly Archives: February 2019

26Feb/19

New Drugs for Multiple Myeloma! Sanofi CD38 Targeted Antibody Therapy – Isatuximab’s First Phase III Clinical Study was Successful

February 26, 2019Antibody Application, Antibody Commercialization, Antibody NewsImmunotherapy Antibody, Monoclonal antibody, Tumor Antibodybio-anti

French pharmaceutical giant Sanofi recently announced that the key phase III clinical study ICARIA-MM to evaluate isatuximab in the treatment of recurrent/refractory multiple myeloma (R/R MM) has reached the main end point. TheRead More…

13Feb/19

Cell: New Research Reveals An Unexpected Mechanism of Action of Antibodies

February 13, 2019Antibody Research, Disease AntibodyAntibody Discovery, Antibody Research, Coronavirus, Monoclonal antibodybio-anti

In a new study, Researchers from institutions such as the University of Washington studied human monoclonal antibodies isolated from survivors of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS)Read More…